The negotiation period for the Inflation Reduction Act’s drug price program ends today, putting millions of Medicare patients on the path to affordable prescription drugs by 2026.
Inflation Reduction Act's Medicare drug price negotiation period ends, edges closer to affordable drugs by 2026
